Zoono Group Ltd. is a pharmaceutical and biotechnology company. The firm is engaged in the development, manufacture, and sale of antimicrobial technology effective against all pathogens including bacteria, viruses, mould, algae, and fungi. Its products include aerosol-based sprays, surface sanitizers, treatment of acne, and mould remediation. The company was founded on October 8, 1986 and is headquartered in Auckland, New Zealand.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company